Article ; Online: Economic burden of respiratory syncytial and parainfluenza viruses in children of upper-middle-income countries: a systematic review.
2023 Volume 99, Issue 6, Page(s) 537–545
Abstract: Objective: To identify and assess the current evidence available about the costs of managing hospitalized pediatric patients diagnosed with Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in upper-middle-income countries.: ... ...
| Abstract | Objective: To identify and assess the current evidence available about the costs of managing hospitalized pediatric patients diagnosed with Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in upper-middle-income countries. Methods: The authors conducted a systematic review across seven key databases from database inception to July 2022. Costs extracted were converted into 2022 International Dollars using the Purchasing Power Parity-adjusted. PROSPERO identifier: CRD42020225757. Results: No eligible study for PIV3 was recovered. For RSV, cost analysis and COI studies were performed for populations in Colombia, China, Malaysia, and Mexico. Comparing the total economic impact, the lowest cost per patient at the pediatric ward was observed in Malaysia ($ 347.60), while the highest was in Colombia ($ 709.66). On the other hand, at pediatric ICU, the lowest cost was observed in China ($ 1068.26), while the highest was in Mexico ($ 3815.56). Although there is no consensus on the major cost driver, all included studies described that the medications (treatment) consumed over 30% of the total cost. A high rate of inappropriate prescription drugs was observed. Conclusion: The present study highlighted how RSV infection represents a substantial economic burden to health care systems and to society. The findings of the included studies suggest a possible association between baseline risk status and expenditures. Moreover, it was observed that an important amount of the cost is destinated to treatments that have no evidence or support in most clinical practice guidelines. |
|---|---|
| MeSH term(s) | Humans ; Child ; Infant ; Developing Countries ; Financial Stress ; Respiratory Syncytial Virus Infections ; Respiratory Syncytial Virus, Human ; Parainfluenza Virus 3, Human ; Hospitalization |
| Language | English |
| Publishing date | 2023-05-26 |
| Publishing country | Brazil |
| Document type | Systematic Review ; Journal Article ; Review ; Research Support, Non-U.S. Gov't |
| ZDB-ID | 731324-x |
| ISSN | 1678-4782 ; 0021-7557 |
| ISSN (online) | 1678-4782 |
| ISSN | 0021-7557 |
| DOI | 10.1016/j.jped.2023.05.003 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.B 1265: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 2021: Bestellungen von Artikeln über das Online-Bestellformular ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.